Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Wednesday, April 24, 2024 | Back issues
Courthouse News Service Courthouse News Service

Cancer Drug

TRENTON, N.J. - Providence, R.I., claims Celgene Corp. is illegally preventing introduction of generic forms of the blockbuster cancer drugs Thalidomide and its Revlimid analogue, in a federal antitrust complaint.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...